Latest News
SILVER SPRING, Maryland (Reuters) ? Heart safety studies should be required for new obesity drugs, U.S. drug advisers said on Thursday, possibly adding a new hurdle to the drugs? approval. An advisory panel to the U.S. Food and Drug Administration voted 17-6 that regulators should make companies conduct heart impact studies in order to sell their drugs in the United States, even if clinical trials do not initially show evidence of increased heart risk. ?Anti-obesity drugs have a bad track record of cardiovascular risk,? said Dr. ?
See the original post here:?
Obesity drugs need heart studies, U.S. advisers say
Source: http://www.healthandfitnesscentre.org/obesity-drugs-need-heart-studies-u-s-advisers-say/
joe frazier dead topamax lexapro trazodone voting sharon bialek call of duty elite
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.